Xiaowen Mao | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Xiaowen Mao | Medicine and Health Sciences | Best Researcher Award

University of Macau | Macau

Dr. Xiaowen Mao, M.D., Ph.D., is an Assistant Professor at the State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, where she leads translational research on cancer biology, immunotherapy, and tumor microenvironment modulation. She earned her Ph.D. in Biomedical Sciences from the University of Hong Kong and her B.Sc. in Clinical Medicine from Shanghai Jiao Tong University, China. Her research focuses on extracellular vesicles, immune homeostasis, metabolic reprogramming in tumors, and hepatocellular carcinoma metastasis, integrating molecular, cellular, and translational approaches. Dr. Xiaowen Mao has led several high-impact projects as principal investigator, funded by the Health and Medical Research Fund, National Natural Science Foundation Young Scientist Fund, and FDCT Innovation and Technology Promotion. Her significant contributions include the development of broadly potent neutralizing antibodies targeting Nidogen 1 to inhibit tumor growth, elucidation of extracellular vesicle-mediated metabolic reprogramming in tumors, and advances in dendritic cell vaccine strategies. She holds a U.S. patent on Nidogen 1 as a diagnostic and therapeutic target for hepatocellular carcinoma, serves as Guest Editor for Frontiers in Endocrinology, and is an ad-hoc reviewer for multiple high-impact journals. According to Scopus, she has 31 publications, 1,114 citations by 1,010 documents, and an h-index of 20. Dr. Xiaowen Mao’s work bridges fundamental research and clinical translation, delivering innovative therapies and advancing precision medicine in oncology, while demonstrating a profound impact on cancer biology, immunotherapy, and translational research.

Profile: Scopus

Featured Publications

  • Xue, T. M., Yeung, C. L. S., Mao, X. W., Tey, S. K., Lo, K. W., Tang, H. N., Yun, J. P., & Yam, J. W. P. (2025). Development of a broadly potent neutralizing antibody targeting Nidogen 1 effectively inhibits cancer growth and metastasis in preclinical tumor models. Journal of Translational Internal Medicine. https://doi.org/10.1515/jtim-2025-0008

  • Xia, L., Li, C. G., Zhao, J., Sun, Q. C., & Mao, X. W.* (2025). Rebalancing immune homeostasis in combating disease: The impact of medicine food homology plants and gut microbiome. Phytomedicine, 136, 156150. https://doi.org/10.1016/j.phymed.2025.156150

  • Chen, Z., Yam, J. W. P., & Mao, X. W.* (2024). The multifaceted roles of small extracellular vesicles in metabolic reprogramming in the tumor microenvironments. Proteomics, e2300021. https://doi.org/10.1002/pmic.202300021

  • Lee, K. W., Yam, J. W. P., & Mao, X. W.* (2023). Dendritic cell vaccines: A shift from conventional approach to new generations. Cells, 12(2147). https://doi.org/10.3390/cells12172147

  • Li, S., Delvecchio, M., Ramkumar, K., Mao, X. W., Sun, X. D., & Guo, S. Z. (2023). Editorial: Clinical and genetic determinants of diabetes and complications. Frontiers in Endocrinology.

Zhechun Wu | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Mr. Zhechun Wu | Medicine and Health Sciences | Best Researcher Award

Chaoyang Hospital | China

Mr. Zhechun Wu is a resident physician in the Department of Urology at Beijing Chaoyang Hospital, Capital Medical University, Beijing, China, who has established himself as an emerging clinician–scientist combining medical training with impactful research. He earned his Bachelor of Science degree from Capital Medical University and is currently advancing his clinical expertise through residency while contributing to translational oncology research. His work is focused on prostate cancer, with particular emphasis on identifying therapeutic targets that regulate tumor immunity, a critical area for developing next-generation treatment strategies. Mr. Zhechun Wu has published in reputable international journals, including a recent article in Investigational New Drugs that explored drug targets modulating tumor immune response, a study that has already been cited in related scholarly work, reflecting its scientific significance. His projects are supported by competitive funding from the National Natural Science Foundation of China  and the Beijing Natural Science Foundation, highlighting his ability to secure prestigious grants and deliver research with clinical and academic value. Alongside research, his clinical practice in urology, oncology, and kidney transplantation strengthens his understanding of patient-centered challenges, allowing him to align laboratory findings with real-world medical needs. This dual role as physician and researcher equips him to contribute to both advancing cancer therapeutics and improving clinical outcomes, establishing a foundation for future leadership in medical innovation and academic research.

Profile: ORCID

Featured Publications

Zhang, Y., Qiu, X., Wu, Z., Li, Y., Shen, X., Wu, J., Cao, P., Sun, Z., & Wang, W. (2025). Comprehensive analysis of the association between volatile organic compound pollutants and chronic kidney disease in hypertensive populations: Insights from multi-omics approaches and identification of potential therapeutic targets. Environmental Research, 121966.

Wu, Z., Li, S., Li, Y., Wang, Z., & Wang, W. (2025). Identifying potential therapeutic targets for prostate cancer with mediating role in tumor immunity. Discover Oncology, 16, 98.

Wu, Z. (2025). Higher sexual frequency correlated with lowered PSA complex levels in U.S. men over 40 and without prostate conditions: A nationwide cross-sectional study. The Journal of Sexual Medicine.

Liliang Li | Medicine and Health Sciences | Excellence in Innovation Award

Published on by Forensic Scientist

Prof. Liliang Li | Medicine and Health Sciences | Excellence in Innovation Award

Fudan University | China

Prof. Liliang Li is a leading Associate Professor at Fudan University Shanghai Medical College, recognized for her pioneering research in forensic medicine, cardiovascular biology, and translational pharmacology. She has made significant contributions to understanding the molecular mechanisms underlying antipsychotic-induced cardiotoxicity, diabetic heart injuries, and sudden unexplained death in psychiatric patients. Combining innovative molecular approaches with clinical applications, Dr. Li’s research has consistently bridged basic science and translational medicine, influencing both diagnostic strategies and therapeutic development.

Professional Profile

Scopus

ORCID

Education

Prof. Liliang Li received her medical degree in Forensic Medicine followed by a doctoral degree in Forensic Science from Fudan University Shanghai Medical College. She enhanced her academic foundation and international exposure through postdoctoral training and a visiting scholar program at the University of Maryland School of Medicine, enabling her to integrate global perspectives into her research.

Experience

Prof. Liliang Li has built an impressive academic and research career, progressing from postdoctoral fellow to Associate Research Fellow, and ultimately assuming her current role as Associate Professor. She has played key roles in mentoring young researchers, organizing graduate research conferences, and serving as a talent specialist. She actively participates in professional committees, including leadership positions within the Shanghai Society of Forensic Medicine, the Shanghai Association of Forensic Expertise, and cardiovascular research societies, demonstrating both scientific excellence and professional commitment.

Research Interests

Her research focuses on the mechanisms of antipsychotic-induced cardiotoxicity, cannabinoid receptor-mediated myocardial signaling, and cell death pathways including necroptosis and pyroptosis. Prof. Liliang Li is particularly interested in the identification of biomarkers for sudden cardiac death and diabetic cardiac injuries. Her work integrates multi-omics approaches, including proteomics, transcriptomics, and molecular biology, to unravel complex cardiovascular and forensic phenomena, with an emphasis on developing translational strategies for clinical and forensic applications.

Awards

Prof. Liliang Li’s innovative work has been widely recognized with numerous prestigious awards, including Young Investigator accolades, national and regional medical science awards, and multiple best paper honors at leading cardiology conferences. She has been nominated for international awards in toxicology, chaired sessions at major scientific meetings, and serves as a reviewer for high-impact journals in cardiovascular medicine, translational research, and molecular biology. These accolades reflect her influence on both national and international scientific communities.

Publications

  • Title: Coenzyme Q deficiency may predispose to sudden unexplained death via an increased risk of cardiac arrhythmia
    Journal: International Journal of Legal Medicine
    Published on: 2024

  • Title: RNF149 Destabilizes IFNGR1 in Macrophages to Favor Postinfarction Cardiac Repair
    Journal: Circulation Research
    Published on: 2024

  • Title: Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
    Journal: Clinical Science
    Published on: 2024

  • Title: Post-mortem genetic analysis of sudden unexplained death in a young cohort: a whole-exome sequencing study
    Journal: International Journal of Legal Medicine
    Published on: 2023

  • Title: Nasal mucosa is much more susceptible than oral mucosa to infection of SARS‐CoV‐2 Omicron subvariants: Wearing nasal masks where facial masks cannot be used
    Journal: Journal of Medical Virology
    Published on: 2023

  • Title: Sudden unexplained death in schizophrenia patients: An autopsy-based comparative study from China
    Journal: Asian Journal of Psychiatry
    Published on: 2023

  • Title: Cannabinoid Receptor 2-Centric Molecular Feedback Loop Drives Necroptosis in Diabetic Heart Injuries
    Journal: Circulation
    Published on: 2023

Conclusion

Prof. Liliang Li is an exceptional scientist whose work exemplifies innovation, rigor, and translational impact. Her integration of forensic science, molecular cardiology, and translational medicine has led to new insights into drug-induced cardiotoxicity and sudden cardiac death. With a remarkable combination of research excellence, leadership, and mentorship, Dr. Li continues to shape the future of cardiovascular and forensic research, making her a highly deserving candidate for the Excellence in Innovation Award.

Arman Soltani Moghadam | Medicine | Best Researcher Award

Published on by Forensic Scientist

Dr. Arman Soltani Moghadam | Medicine | Best Researcher Award

Tehran Herat Center | Iran

Dr. Arman Soltani Moghadam is a dedicated medical doctor and cardiovascular researcher based in Tehran, Iran. With a strong foundation in clinical medicine and an exceptional academic record, he has significantly contributed to cardiology through both clinical practice and extensive research collaborations internationally. Known for his precision in diagnostics and passion for scientific inquiry, he serves as a General Practitioner while actively engaging in cutting-edge cardiovascular research with institutions such as Tehran University of Medical Sciences and the University of Arizona.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Dr. Arman Soltani Moghadam demonstrates a rare blend of clinical expertise, academic excellence, and prolific research productivity at a remarkably early career stage. With dual appointments in top-tier institutions such as Tehran Heart Center and the University of Arizona, he brings international collaboration into practice. His extensive publication record, including meta-analyses in high-impact journals like Journal of the American Heart Association, Clinical Cardiology, and Frontiers in Immunology, underlines his commitment to evidence-based cardiology. His editorial contributions to BMJ and Artificial Organs, as well as multiple conference abstracts presented at AHA and ACC, show active involvement in shaping the scientific dialogue.

Moreover, his ability to work across disciplines—ranging from echocardiography and interventional cardiology to artificial intelligence in medicine—shows a visionary mindset. His numerous certifications from Oxford, Johns Hopkins, and Coursera on clinical trials, machine learning, and statistical methods further reinforce his scientific rigour. Notably, his early leadership as a corresponding author and multiple first-author meta-analyses reflect originality and independence in research.

🎓 Education

Dr. Moghadam earned his Doctor of Medicine (M.D.) diploma from Islamic Azad University, Tehran Medical Sciences Branch (2014–2021), graduating with a commendable GPA of 3.65/4.0. Prior to that, he completed his Diploma in Natural Science at the National Organization for the Development of Exceptional Talents (NODET), where he achieved a perfect GPA of 4.0/4.0. His strong academic foundation reflects his commitment to lifelong learning and excellence in science.

💼 Experience

Currently, Dr. Moghadam works as a General Practitioner at Amiralam Hospital in Tehran, while concurrently contributing as a Research Assistant in the Department of Cardiology at Tehran University of Medical Sciences. He previously served at Chamran Hospital and completed his internship at Islamic Azad University. Additionally, he collaborates remotely with the University of Arizona as a cardiovascular research assistant, showcasing his global engagement in healthcare research.

🔬 Research Interests On Medicine

Dr. Moghadam’s research is rooted in cardiology, with focused interests in interventional cardiology, structural heart disease, electrophysiology, and echocardiography. His studies aim to bridge clinical observations with evidence-based medicine, frequently employing meta-analytical techniques and advanced statistical tools. He is passionate about improving cardiovascular outcomes through innovation and collaboration.

🏆 Awards and Honors

🏅 Ranked 1st in the Clinical Knowledge Exam among his peers, Dr. Moghadam also secured 2nd position based on GPA in his MD program. He is a recognized member of the Iranian Society of Atherosclerosis (IR SA) and actively participates in national and international scientific communities. His commitment to education is evident from his extensive teaching and mentoring experiences.

📄 Publications

  • Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review
    Authors: AB Boroumand, M Forouhi, F Karimi, AS Moghadam, LG Naeini, …
    Year: 2022
    Cited by: 58

  • Human diseases Research and textbook 1: Heart, Diabetes, Bacterial, ADHD, skin
    Authors: AT Mohammadi, S Karami, A Jahandideh, S Sarejloo, S Vaseghi, …
    Year: 2022
    Cited by: 29

  • The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review
    Authors: A Vakilpour, E Amini-Salehi, A Soltani Moghadam, MH Keivanlou, …
    Year: 2024
    Cited by: 21

  • Emerging Technologies in Medicine: Artificial Intelligence, Robotics, and Medical Automation
    Authors: M Rezaei, S Saei, SJ Khouzani, ME Rostami, M Rahmannia, …
    Year: 2023
    Cited by: 21

  • In Patients with Cardiogenic Shock, Extracorporeal Membrane Oxygenation Is Associated with Very High All-Cause Inpatient Mortality Rate
    Authors: MR Movahed, A Soltani Moghadam, M Hashemzadeh
    Year: 2024
    Cited by: 1

  • Gender-based Disparity in Performing Aortic Valve Surgery in the United State Before Availability of Percutaneous Valve Implantation
    Authors: MR Movahed, AS Moghadam, M Hashemzadeh, M Hashemzadeh
    Year: 2024
    Cited by: 1

  • Revisiting echocardiographic features of prosthetic heart valves: the necessity of correct differentiation of mono-leaflet vs. bileaflet mechanical heart valves in a case report
    Authors: SHAASM Farnoosh Larti’t, Babak Geraiely’t
    Year: 2024
    Cited by: 1

  • Intravascular Lithotripsy Versus Rotational Atherectomy in the Management of Calcific Coronary Lesions: A Systematic Review and Meta‐Analysis
    Authors: AS Moghadam, N Kakavand, FO Shirmard, A Poopak, N Anaraki, …
    Year: 2025
    Cited by: Not available

  • Short‐Term, Mid‐Term, and Long‐Term Outcomes of Transcatheter Aortic Valve Replacement With Balloon‐Expandable Versus Self‐Expanding Valves: A Meta‐Analysis of Randomized Trials
    Authors: K Tavakoli, NSH Mohammadi, P Bahiraie, S Saeidi, F Shaker, …
    Year: 2025
    Cited by: Not available

  • Time Trend Analysis of Clinical Outcomes for Drug-Coated Balloon versus Drug-Eluting Stent among Patients with Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Trials
    Authors: A Soltani Moghadam, S Kazemian, S Shojaei, Saman Soltani Moghadam, …
    Year: 2024
    Cited by: Not available

✅ Conclusion

Dr. Arman Soltani Moghadam exemplifies the fusion of clinical acumen and research innovation. With a diverse portfolio of international collaborations, high-impact publications, and a continuous pursuit of academic and clinical excellence, he stands as a strong nominee for any global medical or research award. His contributions not only enhance cardiovascular knowledge but also inspire the next generation of physician-scientists.

Jinhui Ma | Medicine | Best Researcher Award

Published on by Forensic Scientist

Dr. Jinhui Ma | Medicine | Best Researcher Award

Associate doctor | China-Japan Friendship Hospital | China

A dedicated orthopedic specialist at China-Japan Friendship Hospital, Department of Bone and Joint Surgery, serving as an Associate Chief Physician, with profound expertise in diagnosing and treating complex bone and joint conditions. His commitment to advancing orthopedic care is exemplified by his contributions to clinical research, academic publications, and medical education.

Professional profile👤

Scopus

Strengths for the Awards✨

  • Extensive Clinical Expertise: Specializes in diagnosing and treating complex bone and joint diseases, with a focus on early treatment of osteonecrosis of the femoral head and hip preservation techniques.
  • Research Excellence: Has led notable research projects, including one funded by the Beijing Natural Science Youth Fund and another by the China-Japan Friendship Hospital, while contributing to three National Natural Science Foundation projects.
  • Publication Record: As first and co-first author, has published 17 SCI articles and nearly 8 core journal articles, showcasing a strong contribution to the academic community.
  • Academic Contributions: Participated in compiling three orthopedic books and contributed to the development of two utility model patents.
  • Recognition and Awards: Recipient of the “Outstanding Scientific Research Award” and “Excellent Graduate” award from Peking University, reflecting research excellence.
  • Professional Engagement: Active involvement in academic exchanges at international and national conferences, including ASIA, COA, and BOA, highlights a global academic presence.
  • Leadership Roles: Holds multiple editorial board positions and leadership roles in prestigious medical societies, further emphasizing professional recognition.

Education 🎓

He earned his Doctorate in Clinical Medicine from the Peking University Health Science Center, where he was recognized as an “Excellent Graduate” and received the “Outstanding Scientific Research Award.”

Experience 💼

He honed his skills at Queen Mary Hospital of the University of Hong Kong, specializing in joint replacement technology. He has extensive experience in early treatment of osteonecrosis of the femoral head, hip preservation, osteoarthritis, rheumatoid arthritis, hip dysplasia, motor system injuries, total knee and hip replacements, as well as knee and shoulder arthroscopy.

Research Interests On Medicine 🔬

His research focuses on the diagnosis and treatment of osteonecrosis of the femoral head, hip preservation techniques, advancements in joint replacement, and improving outcomes in complex bone and joint diseases.

Awards 🏆

  • Excellent Graduate of Peking University
  • Outstanding Scientific Research Award, Peking University
  • First Prize, Battle of 100 Groups, China Association for Health Promotion and Education
  • Third Prize, Chinese Orthopedic Good Doctor Reading Contest, Chinese Journal of Bone and Joint Surgery
  • Excellent Prize, Speech Contest (Beijing), Editorial Committee of the Chinese version of JBJS

Publications 📖

He has authored 17 SCI articles and nearly 8 papers in core journals as the first or co-first author. Additionally, he participated in the compilation of three orthopedic books, such as “Osteonecrosis and Strategies for Diagnosis and Treatment of Joint Surgery.”

  • Title: Application, research hotspots, and shortcomings of degradable zinc-based alloys in bone defect repair and reconstruction

    • Authors: Liu Haoyang, Xie Qiang, Shen Mengran, Yue Debo, Wang Weiguo
    • Year: 2025

  • Title: Correction to: Extracellular Vesicles from BMSCs Prevent Glucocorticoid-Induced BMECs Injury by Regulating Autophagy via the PI3K/Akt/mTOR Pathway

    • Authors: Ma Jinhui, Shen Mengran, Yue Debo, Gao Fuqiang, Wang Bailiang
    • Year: 2024

  • Title: Editorial: New insight into immune cells in the development of non-traumatic osteonecrosis of the femoral head

    • Authors: Zhou Yu, Ma Jinhui, Zhang Qingyu, Wang Bailiang
    • Year: 2024

  • Title: Interleukin-33-mediated bone immunity

    • Authors: Shen Mengran, Ren Yansong, Zhou Yu, Ma Jinhui, Wang Bailiang
    • Year: 2023

Professional Contributions

He has led one Beijing Natural Science Youth Fund project, one China-Japan Friendship Hospital project, and contributed to three National Natural Science Foundation projects. His work also includes developing two utility model patents. Academically, he has presented at prestigious conferences like the Asian Association of Joint Replacement (ASIA), National Association of Orthopaedics (COA), and Beijing Orthopedic Association (BOA).

Professional Memberships 🔒

He serves as Secretary General of the Orthopedic Group of the Professional Committee of Translational Medicine of the Chinese Society of Microcirculation and holds memberships in:

  • Young and Middle-aged Editorial Committees of the Chinese Journal of Trauma, Chinese Journal of Reconstructive Surgery, Chinese Journal of Tissue Engineering, and Traditional Chinese Medicine Bone Setting.
  • Youth Working Committee of the Professional Committee of Translational Medicine, Chinese Society of Microcirculation.
  • Expert Committee on Bone Circulation and Osteonecrosis, Professional Committee of Shock Wave Medicine, Chinese Research Hospital Association.

Conclusion 🌟

His remarkable contributions to orthopedics, spanning clinical practice, research, and academic engagement, have made a lasting impact on the field. His passion for advancing orthopedic care and educating future generations continues to shape the future of bone and joint surgery.

Kevin Pak | Medicine | Best Researcher Award

Published on by Forensic Scientist

Dr. Kevin Pak | Medicine | Best Researcher Award

Transplant Hepatology Fellow | UCLA | United States

Dr. Kevin C. Pak, M.D., is a distinguished transplant hepatologist affiliated with the Pflieger Liver Institute at the David Geffen School of Medicine at UCLA. With a strong background in internal medicine, gastroenterology, and hepatology, Dr. Pak has dedicated his career to advancing liver disease treatment and transplantation. His contributions to academic research and clinical practice have earned him recognition in the medical community.

Profile👤

Google Scholar

Scopus

Strengths for the Awards✨

✅ Exceptional Research Contributions: Dr. Pak has an extensive portfolio of peer-reviewed publications in prestigious journals, covering a range of topics in gastroenterology, hepatology, and military medicine. His research on hepatitis B, hepatocellular carcinoma, liver transplantation, and inflammatory bowel disease is particularly noteworthy.

✅ Clinical and Academic Leadership: As an Assistant Professor at USUHS and a former Chief Fellow in a gastroenterology fellowship, Dr. Pak has demonstrated strong mentorship and leadership in academic medicine. His contributions to teaching and training future physicians further emphasize his dedication to research and education.

✅ Recognized Excellence: Multiple honors and awards, including the AASLD Emerging Liver Scholar Award (2019) and Resident Researcher of the Year, highlight his significant impact in the field. His invited presentations and poster sessions at national and international conferences further validate his research reputation.

✅ Interdisciplinary and Military Medicine Contributions: His unique background in military medicine and research contributions in military healthcare settings (e.g., inflammatory bowel disease in active-duty personnel) provide a broader impact beyond civilian medicine.

Education 🎓

Dr. Pak began his academic journey at the United States Military Academy (USMA) in West Point, New York, earning a B.S. in Life Sciences. He then pursued his medical degree at the F. Edward Hébert School of Medicine at the Uniformed Services University of the Health Sciences (USUHS) in Bethesda, Maryland. His postgraduate training includes an Internal Medicine Residency at Walter Reed National Military Medical Center, followed by a Gastroenterology & Hepatology Fellowship at Naval Medical Center San Diego. He further specialized in Transplant Hepatology through a fellowship at the Pflieger Liver Institute at UCLA.

Experience 💼

Dr. Pak has held several academic positions, including Assistant Professor of Medicine and Teaching Fellow at USUHS. He is actively involved in medical education, mentoring students and residents. His clinical expertise spans hepatology, transplant medicine, and gastroenterology, making him a key contributor to the field. Additionally, Dr. Pak has served in the military, where he provided medical services in critical care settings.

Research Interests On Medicine🔬

Dr. Pak’s research focuses on liver disease, hepatocellular carcinoma, chronic hepatitis B, and liver transplantation. He is particularly interested in optimizing treatment strategies for liver disease and investigating emerging therapies. His work contributes to advancements in hepatology, improving patient outcomes and clinical practices.

Awards 🏆

Dr. Pak has received numerous accolades throughout his career. He was honored with the Resident Researcher of the Year Award and the AASLD Emerging Liver Scholar Award. His excellence in teaching earned him the James J. Leonard Award for Excellence in Teaching. In his military service, he received commendations such as the Navy/Marine Corps Commendation Medal and the Joint Service Commendation Medal.

Publications 📚

Dr. Pak has authored multiple peer-reviewed publications in prestigious journals. His notable works include:

  • Systematic review of safety of selective androgen receptor modulators in healthy adults: implications for recreational users

    • Authors: JD Vignali, KC Pak, HR Beverley, JP DeLuca, JW Downs, AT Kress, …
    • Publication Year: 2023
    • Citations: 38

  • Wilson’s disease and iron overload: pathophysiology and therapeutic implications

    • Authors: K Pak, S Ordway, B Sadowski, M Canevari, D Torres
    • Publication Year: 2021
    • Citations: 23

  • Helicobacter pylori Treatment Regimen Selection and Eradication Rates Across Department of Defense Patients for Fiscal Years 2016-2018

    • Authors: ZC Junga, A Mertz, K Pak, M Singla
    • Publication Year: 2023
    • Citations: 9

  • The Patterns and Associated Cost of Serologic Testing for Helicobacter pylori in the U.S. Military Health System

    • Authors: K Pak, Z Junga, A Mertz, M Singla
    • Publication Year: 2020
    • Citations: 6

  • State of the art: Test all for anti-hepatitis D virus and reflex to hepatitis D virus RNA polymerase chain reaction quantification

    • Authors: E Umukoro, JJ Alukal, K Pak, J Gutierrez
    • Publication Year: 2023
    • Citations: 5

  • Occult HBV infection: a case series at a military treatment facility

    • Authors: K Pak, S Ordway, D Torres
    • Publication Year: 2020
    • Citations: 4

  • An acute presentation of chronic gastric volvulus

    • Authors: K Pak, Z Junga, P Young
    • Publication Year: 2020
    • Citations: 4

  • Decades of cough: Delayed recognition of atypical cystic fibrosis in an adult patient

    • Authors: A Chandel, K Pak, S Dooley, K Salazar
    • Publication Year: 2020
    • Citations: 3

  • A small blemish: isotretinoin-induced microscopic colitis

    • Authors: LR Dukate, K Pak, W O’Connell, Z Junga
    • Publication Year: 2022
    • Citations: 2

  • A Case of Whipple’s Disease With Concomitant Esophageal Candidiasis

    • Authors: R Choi, A Pazevic, K Pak, M Skaret, A Bachmann, R Wilkerson
    • Publication Year: 2024
    • Citations: 1

Conclusion 🔍

Dr. Kevin C. Pak, M.D., is a dedicated physician, educator, and researcher in hepatology and gastroenterology. His commitment to advancing liver disease treatment, coupled with his academic and clinical expertise, makes him a key figure in the field. Through his research, mentorship, and clinical practice, Dr. Pak continues to contribute significantly to medical science and patient care.

Hyung-Youl Park | Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Hyung-Youl Park | Health Sciences | Best Researcher Award

Assistant Professor | Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea | South Korea 

Dr. Hyung-Youl Park is a Clinical Assistant Professor in the Department of Orthopedic Surgery at Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea. With a focus on spinal cord injuries, disc degeneration, adult spinal deformity, minimally invasive surgery, and osteoporosis, Dr. Park has established himself as a leading figure in both clinical and academic orthopedic surgery. His dedication to improving spinal health is evident in his extensive research, teaching, and clinical expertise.

Profile

Orcid

Strenghts for the Awards

  • Prolific Research Output:
    Dr. Hyung-Youl Park has published extensively, with 72 research articles, including 50 high-impact works in prestigious journals like the European Spine Journal, Diagnostics, World Neurosurgery, and Clinical Orthopaedics and Related Research. His contributions reflect a consistent focus on advancing orthopedic surgery, spinal diseases, and geriatric spinal care.
  • Diverse and Impactful Research Areas:
    His research spans critical topics such as:

    • Risk factors for mechanical complications in spinal surgeries.
    • Pathophysiology and treatment of Kummell’s Disease.
    • Effects of telemedicine on medical staff post-COVID-19.
    • Innovations in bone regeneration and biomaterials.
    • Geriatric spinal fusion and osteoporosis treatment strategies.
    • Surgical management of spinal metastases and deformities.

    These studies showcase clinical relevance and translational impact on improving patient outcomes, particularly in geriatric and oncology-related spinal care.

  • Collaboration and Leadership:
    Dr. Park has co-authored with notable experts like Young-Hoon Kim and Kee-Yong Ha, reflecting his active collaboration in multidisciplinary teams. His involvement in pivotal studies, such as surgical risk factors, spinal imaging, and regenerative medicine, indicates leadership in shaping clinical practices.
  • High-Impact Publications:
    Many of his works are published in journals indexed in Web of Science and Scopus, with notable DOI-linked contributions that enhance global accessibility. His study on telemedicine satisfaction post-pandemic (Telemedicine and e-Health, 2024) and innovative use of recombinant human BMP-2 (Bioengineering, 2023) demonstrate cutting-edge advancements.
  • Clinical Relevance and Recognition:
    Dr. Park’s research addresses real-world challenges, such as post-surgical complications, lumbar stenosis, and adjacent segment degeneration. His findings offer actionable insights for surgical decision-making and patient care optimization.

Education 🎓

Dr. Park holds an impressive academic background:

  • Ph.D. in Orthopedic Surgery (2022), The Catholic University Graduate School, Seoul, Korea.
    • Dissertation: “Are the Choice of Frame and Intraoperative Patient Positioning Associated with Radiologic and Clinical Outcomes in Long-Instrumented Lumbar Fusion for Adult Spinal Deformity?”
  • M.D. (2012), The Catholic University, College of Medicine, Seoul, Korea.

His postgraduate training includes internships, residency, and fellowships at renowned hospitals within the Catholic Medical Center in Korea.

Experience 🏥

Dr. Park’s professional journey spans over a decade of clinical expertise:

  • Clinical Assistant Professor (2020 – Present): Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea.
  • Clinical Fellow (2017–2020): Department of Orthopedic Surgery at Seoul and Eunpyeong St. Mary’s Hospitals.
  • Orthopedic Resident (2013–2017): Seoul St. Mary’s Hospital, Catholic Medical Center, Seoul, Korea.

He actively teaches medical students and residents and has played a pivotal role in weekly spine disorder reviews and conferences.

Research Interests 🔬

Dr. Park’s primary research interests include:

  • Spinal cord injury and disc degeneration.
  • Adult spinal deformity and minimally invasive spine surgery.
  • Osteoporosis and its effects on spinal health.

His research integrates basic science with clinical applications to improve patient outcomes in spine surgery.

Awards and Recognitions 🏆

Dr. Park’s work has earned numerous accolades:

  • Young Investigator Award, Korean Society of Spinal Surgery (2023).
  • Best Investigator Award, Department of Orthopedic Surgery, The Catholic University of Korea (2022).
  • Oral Presentation Awards for innovative research in osteoporosis and spinal tumors at multiple national and international congresses (2016–2021).
  • Nomination for Hibbs Award, Scoliosis Research Society (2017).

These honors reflect his commitment to advancing orthopedic surgery through groundbreaking research.

Publications 📚

Dr. Hyung-Youl Park has authored several impactful articles in high-ranking journals:

  1. “Risk factors for mechanical complications after fusion extension surgery for lumbar adjacent segment disease”
    • Authors: Kim, Young-Hoon; Ha, Kee-Yong; Ahn, Joonghyun; Park, Hyung-Youl; Chang, Dong-Gune; Lim, Jae-Hak; Kim, Sang-Il
    • Journal: European Spine Journal
    • DOI: 10.1007/S00586-023-07880-5
  2. “Understanding Kummell’s Disease: Definition, Diagnosis, Pathophysiology, and Treatment”
    • Authors: Young-Il Ko; Myung-Sup Ko; Chungwon Bang; Hyung-Youl Park; Sang-Il Kim; Young-Hoon Kim
    • Journal: Journal of Korean Society of Spine Surgery
    • DOI: 10.4184/jkss.2024.31.1.23
  3. “Sagittal Realignment Following Decompression for Lumbar Spinal Stenosis in Elderly Patients: A Comprehensive EOS Imaging Analysis”
  4. “Satisfaction Survey of Medical Staff for Telemedicine after the COVID-19 Pandemic”
    • Authors: Seung Eun Jung; Young-Mi Kwon; Soon-Yong Kwon; Young-Hoon Kim; Hyung-Youl Park
    • Journal: Telemedicine and e-Health
    • DOI: 10.1089/tmj.2024.0142
  5. “The Effects of Longer Use of Teriparatide on Clinical and Radiographic Outcomes after Spinal Fusion in Geriatric Patients”
    • Authors: Young-Hoon Kim; Kee-Yong Ha; Hyun W. Bae; Hyung-Youl Park; Young-Il Ko; Myung-Sup Ko; Sang-Il Kim
    • Journal: Medicina
    • DOI: 10.3390/medicina60060946
  1. “Effects of bone cement augmentation for uppermost instrumented vertebra on adjacent disc segment degeneration in lumbar fusions”
    • Authors: Lee, Jae-Won; Kim, Hun-Chul; Kim, Sang-Il; Min, Hyung-Ki; Ha, Kee-Yong; Park, Hyung-Youl; Cho, Chang-Hee; Sung, Hoon-Seok; Lim, Jae-Hak; Kim, Young-Hoon
    • Journal: World Neurosurgery
    • DOI: 10.1016/J.WNEU.2022.11.014
  2. “Junctional Failures at Both Ends After Long Fusion Arthrodesis Stopping at L5: Incidences and Risk Factors”
    • Authors: Kim, Y.-H.; Ha, K.-Y.; Park, H.-Y.; Ko, M.-S.; Ko, Y.-I.; Sin, K.-J.; Kim, S.-I
    • Journal: World Neurosurgery
    • DOI: 10.1016/j.wneu.2023.09.063
  3. “Predictive factors for conversion from conservative to surgical treatment in osteoporotic thoracolumbar compression fractures”
    • Authors: Sung, Hoon-Seok; Kim, Sang-Il; Park, Hyung-Youl; Ko, Myung-Sup; Lee, Jeong-Han; Kim, Young-Hoon
    • Journal: European Spine Journal
    • DOI: 10.1007/S00586-023-07864-5
  4. “Risk Factors for Conversion to Open Spinal Surgery after Percutaneous Epidural Neuroplasty”
    • Authors: Young-Hoon Kim; Sang-Il Kim; Jun-Seok Lee; Hyung-Youl Park
    • Journal: Journal of Korean Society of Spine Surgery
    • DOI: 10.4184/jkss.2023.30.1.18
  5. “When Should Spinal Surgery Be Considered for Spinal Metastasis from Non-Small Cell Lung Cancer?”
    • Authors: Hyung-Youl Park; Kee-Yong Ha; Sang-Il Kim; Yeon-Sil Kim; Yongwon Joh; Young-Hoon Kim
    • Journal: Journal of Clinical Medicine
    • DOI: 10.3390/jcm12144683

Conclusion

Dr. Hyung-Youl Park is a distinguished orthopedic surgeon, educator, and researcher dedicated to advancing spine health through innovative clinical practices and impactful research. His achievements reflect a blend of clinical expertise, academic excellence, and a passion for improving patient outcomes.